Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for In-Process Filtrate Clarity Testing – V 2.0

Posted on By

API Manufacturing: SOP for In-Process Filtrate Clarity Testing – V 2.0

Standard Operating Procedure for In-Process Filtrate Clarity Testing in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/099/2025
Supersedes SOP/API/099/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define a standardized procedure for performing clarity testing of filtrates collected during filtration steps in API manufacturing, ensuring absence of particulate matter and confirming filtration integrity.

2. Scope

This SOP applies to all visual clarity checks carried out during intermediate and final filtration steps in API manufacturing processes.

3. Responsibilities

  • Production Chemist: Collect samples for clarity testing and perform initial
visual observation.
  • QC Analyst: Review and document results of clarity observations and initiate re-filtration if required.
  • QA Officer: Approve clarity test reports and verify documentation accuracy.
  • 4. Accountability

    The Production Head is accountable for implementing clarity checks. QA Head is responsible for ensuring compliance and traceability of the filtration monitoring process.

    5. Procedure

    5.1 Sampling

    1. Collect ~50 mL of filtrate sample in a clean, transparent glass beaker or vial immediately after filtration.
    2. Ensure the sample is free from any contamination introduced during collection.

    5.2 Visual Clarity Observation

    1. Place the beaker against a white and black background under adequate illumination (minimum 1000 lux).
    2. Observe for any visible particulate matter, turbidity, or haziness.
    3. If necessary, use a flashlight at a 45-degree angle to enhance visibility of suspended matter.
    4. Compare sample with a standard blank (solvent or clean filtered water) for reference.

    5.3 Acceptance Criteria

    1. The filtrate must appear clear and free from any suspended particles or haziness.
    2. In case of visible particles:
      • Repeat filtration using the same or finer filter media.
      • Record deviation and escalate to QA if multiple occurrences are noted.

    5.4 Documentation

    1. Record clarity test results in the Filtrate Clarity Logbook (Annexure-1).
    2. Include:
      • Date and time of test
      • Batch number
      • Filtration stage
      • Observation (Clear / Hazy / Particulate matter)
      • Initials of observer
    3. Attach photographic evidence if required by QA or SOP deviation process.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • QC: Quality Control
    • BMR: Batch Manufacturing Record

    7. Documents

    1. Filtrate Clarity Logbook (Annexure-1)
    2. Batch Manufacturing Record
    3. Deviation Form (if applicable)

    8. References

    • ICH Q7 – Good Manufacturing Practice for APIs
    • 21 CFR Part 211 – US FDA GMP
    • WHO TRS 986 – GMP Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Filtrate Clarity Logbook

    Date Batch No. Filtration Stage Observation Performed By Remarks
    13/04/2025 API-20250413 Post-Reaction Filtration Clear Complies

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial Release Process Monitoring SOP QA Head
    13/04/2025 2.0 Added flashlight and photographic comparison techniques GMP Enhancement QA Head
    See also  API Manufacturing: SOP for Vacuum Drying Procedure - V 2.0
    API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

    Post navigation

    Previous Post: Analytical Method Development: Titrimetric Assay Development for Alkalinity – V 2.0
    Next Post: Elixir Department: SOP for Recording Dispensed Quantities in BMR – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version